🇺🇸 FDA
Patent

US 10189859

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

granted A61KA61K31/496A61K31/53

Quick answer

US patent 10189859 (Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine) held by Nektar Therapeutics expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/496, A61K31/53, A61P, A61P25/02